Vizient Applauds House Judiciary Committee for Advancing CREATES Act, and other Drug Pricing Legislation

May 2, 2019 |

2 min read

Vizient commends the House Judiciary Committee for advancing the CREATES Act, and three other pieces of bipartisan legislation designed to promote competition and lower drug prices

IRVING, Texas--(BUSINESS WIRE)-- Vizient commends the House Judiciary Committee for advancing the CREATES Act, and three other pieces of bipartisan legislation designed to promote competition and lower drug prices.

Vizient has strongly supported the CREATES Act, which will take needed steps to support generic manufacturers market access to needed samples that will help to bolster generic competition.

“We are pleased to see the House Judiciary Committee advance the CREATES Act and other bipartisan bills aimed at lowering drug prices,” said Shoshana Krilow, vice president of public policy and government relations for Vizient. “We thank the House committee for their action and urge Congress to quickly approve this important legislation so patients and hospitals can gain access to less-costly essential medications.”

Vizient is the nation’s largest health care performance improvement company serving a diverse membership that includes academic medical centers, pediatric facilities, community hospitals, integrated health care delivery networks and non-acute health care providers.

About Vizient, Inc.

Vizient, Inc., the largest member-driven health care performance improvement company in the country, provides innovative data-driven solutions, expertise and collaborative opportunities that lead to improved patient outcomes and lower costs. Vizient’s diverse membership base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents approximately $100 billion in annual purchasing volume. The Vizient brand identity represents the integration of VHA Inc., University HealthSystem Consortium and Novation, which combined in 2015, as well as MedAssets’ Spend and Clinical Resource Management (SCM) segment, including Sg2, which was acquired in 2016. In 2019, Vizient again received a World’s Most Ethical Company designation from the Ethisphere Institute. Vizient’s headquarters are in Irving, Texas, with locations in Chicago and other cities across the United States. Please visit www.vizientinc.com as well as our newsroom, blog, Twitter, LinkedIn and YouTube pages for more information about the company.